A novel hypothesis for Alzheimer's disease based on neuronal tetraploidy induced by p75NTR

Cell Cycle

Volumn 9, Issue 10, 2010, Pages 1934-1941

  Frade, José M ^a   López Sánchez, Noelia ^a  

^a INSTITUTO CAJAL   (Spain)

Author keywords

Alzheimer's disease; ApoE; A ; BDNF; Cell cycle; Endoreduplication; Neuronal hypertrophy; Oxidative stress; proNGF; Tau

Indexed keywords

AMYLOID BETA PROTEIN; APOLIPOPROTEIN E; BRAIN DERIVED NEUROTROPHIC FACTOR; CYCLINE; NERVE GROWTH FACTOR; NEUROTROPHIN RECEPTOR P75; TAU PROTEIN; TRANSCRIPTION FACTOR E2F1;

AGING; ALZHEIMER DISEASE; APOPTOSIS; CELL CYCLE; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL HYPERPLASIA; CELL VIABILITY; ENDOREDUPLICATION; FLUORESCENCE IN SITU HYBRIDIZATION; HYPOTHESIS; MITOSIS; NERVE CELL; NERVE CELL DIFFERENTIATION; NERVE DEGENERATION; NEUROFIBRILLARY TANGLE; OXIDATIVE STRESS; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RETINA GANGLION CELL; REVIEW; TETRAPLOIDY;

EID: 77953647392     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/cc.9.10.11582     Document Type: Review

References (165)

1. Goedert M, Spillantini MG. A century of Alzheimer's disease. Science 2006; 314:37-9.
2. Vincent I, Pae CI, Hallows JL. The cell cycle and human neurodegenerative disease. Prog Cell Cycle Res 2003; 5:31-41.
3. Rashidian J, Iyirhiaro G, Aleyasin H, Rios M, Vincent I, Callaghan S, et al. Multiple cyclin-dependent kinases signals are critical mediators of ischemia/hypoxic neuronal death in vitro and in vivo. Proc Natl Acad Sci USA 2005; 102:14080-5. (Pubitemid 41377706)
4. Staropoli JF. Tumorigenesis and neurodegeneration: two sides of the same coin? Bioessays 2008; 30:719-27.
5. Busser J, Geldmacher DS, Herrup K. Ectopic cell cycle proteins predict the sites of neuronal cell death in Alzheimer's disease brain. J Neurosci 1998; 18:2801-7. (Pubitemid 28163210)
6. Vincent I, Zheng JH, Dickson DW, Kress Y, Davies P. Mitotic phosphoepitopes precede paired helical filaments in Alzheimer's disease. Neurobiol Aging 1998; 19:287-96.
7. Yang Y, Mufson EJ, Herrup K. Neuronal cell death is preceded by cell cycle events at all stages of Alzheimer's disease. J Neurosci 2003; 23:2557-63.
8. Suzuki T, Oishi M, Marshak DR, Czernik AJ, Nairn AC, Greengard P. Cell cycle-dependent regulation of the phosphorylation and metabolism of the Alzheimer amyloid precursor protein. EMBO J 1994; 13:1114-22. (Pubitemid 24074718)
9. 2/mitosis in cortical precursors from mice lacking beta-amyloid precursor protein. Neuroscience 2005; 130:51-60.
10. Kanemaru K, Takio K, Miura R, Titani K, Ihara Y. Fetal-type phosphorylation of the tau in paired helical filaments. J Neurochem 1992; 58:1667-75.
11. Goedert M, Jakes R, Crowther RA, Six J, Lübke U, Vandermeeren M, et al. The abnormal phosphorylation of tau protein at Ser-202 in Alzheimer disease recapitulates phosphorylation during development. Proc Natl Acad Sci USA 1993; 90:5066-70.
12. Heintz N. Cell death and the cell cycle: a relationship between transformation and neurodegeneration? Trends Biochem Sci 1993; 18:157-9.
13. Smith TW, Lippa CF. Ki-67 immunoreactivity in Alzheimer's disease and other neurodegenerative disorders. J Neuropathol Exp Neurol 1995; 54:297-303.
14. Vincent I, Rosado M, Davies P. Mitotic mechanisms in Alzheimer's disease? J Cell Biol 1996; 132:413-25.
15. Vincent I, Jicha G, Rosado M, Dickson DW. Aberrant expression of mitotic cdc2/cyclin B1 kinase in degenerating neurons of Alzheimer's disease brain. J Neurosci 1997; 17:3588-98. (Pubitemid 27200586)
16. Ding XL, Husseman J, Tomashevski A, Nochlin D, Jin LW, Vincent I. The cell cycle Cdc25A tyrosine phosphatase is activated in degenerating postmitotic neurons in Alzheimer's disease. Am J Pathol 2000; 157:1983-90.
17. Vincent I, Bu B, Hudson K, Husseman J, Nochlin D, Jin L. Constitutive Cdc25B tyrosine phosphatase activity in adult brain neurons with M phase-type alterations in Alzheimer's disease. Neuroscience 2001; 105:639-50. (Pubitemid 32566520)
18. Tomashevski A, Husseman J, Jin LW, Nochlin D, Vincent I. Constitutive Wee1 activity in adult brain neurons with M phase-type alterations in Alzheimer neurodegeneration. J Alzheimers Dis 2001; 3:195-207. (Pubitemid 32566520)
19. Tsujioka Y, Takahashi M, Tsuboi Y, Yamamoto T, Yamada T. Localization and expression of cdc2 and cdk4 in Alzheimer brain tissue. Dement Geriatr Cogn Disord 1999; 10:192-8. (Pubitemid 29224495)
20. Pei JJ, Braak H, Gong CX, Grundke-Iqbal I, Iqbal K, Winblad B, et al. Upregulation of cell division cycle (cdc) 2 kinase in neurons with early stage Alzheimer's disease neurofibrillary degeneration. Acta Neuropathol 2002; 104:369-76.
21. Nagy Z, Esiri MM, Cato AM, Smith AD. Cell cycle markers in the hippocampus in Alzheimer's disease. Acta Neuropathol 1997; 94:6-15. (Pubitemid 27289096)
22. Johansson A, Hampel H, Faltraco F, Buerger K, Minthon L, Bogdanovic N, et al. Increased frequency of a new polymorphism in the cell division cycle 2 (cdc2) gene in patients with Alzheimer's disease and frontotemporal dementia. Neurosci Lett 2003; 340:69-73. (Pubitemid 36324496)
23. Johansson A, Zetterberg H, Hampel H, Buerger K, Prince JA, Minthon L, et al. Genetic association of CDC2 with cerebrospinal fluid tau in Alzheimer's disease. Dement Geriatr Cogn Disord 2005; 20:367-74. (Pubitemid 41642795)
24. Bosco P, Caraci F, Copani A, Spada RS, Sortino MA, Salluzzo R, et al. The CDC2 I-G-T haplotype associated with the APOE epsilon4 allele increases the risk of sporadic Alzheimer's disease in Sicily. Neurosci Lett 2007; 419:195-8.
25. Liang X, Schnetz-Boutaud N, Bartlett J, Anderson BM, Gwirtsman H, Schmechel D, et al. Association analysis of genetic polymorphisms in the CDC2 gene with late-onset Alzheimer disease. Dement Geriatr Cogn Disord 2007; 23:126-32.
26. Yang Y, Geldmacher DS, Herrup K. DNA replication precedes neuronal cell death in Alzheimer's disease. J Neurosci 2001; 21:2661-8. (Pubitemid 32298208)
27. Bonda DJ, Evans TA, Santocanale C, Llosá JC, Viña J, Bajic VP, et al. Evidence for the Progression through S-phase in the Ectopic Cell Cycle Re-entry of Neurons in Alzheimer Disease. Aging 2009; 1:382-8.
28. Jordan-Sciutto KL, Malaiyandi LM, Bowser R. Altered distribution of cell cycle transcriptional regulators during Alzheimer disease. J Neuropathol Exp Neurol 2002; 61:358-67. (Pubitemid 34266787)
29. Thakur A, Siedlak SL, James SL, Bonda DJ, Rao A, Webber KM, et al. Retinoblastoma Protein Phosphorylation at Multiple Sites is Associated with Neurofibrillary Pathology in Alzheimer Disease. Int J Clin Exp Pathol 2008; 1:134-46.
30. McShea A, Harris PL, Webster KR, Wahl AF, Smith MA. Abnormal expression of the cell cycle regulators P16 and CDK4 in Alzheimer's disease. Am J Pathol 1997; 150:1933-9. (Pubitemid 27233067)
31. Nagy Z, Esiri MM, Smith AD. Expression of cell division markers in the hippocampus in Alzheimer's disease and other neurodegenerative conditions. Acta Neuropathol 1997; 93:294-300. (Pubitemid 27104426)
32. Hoozemans JJ, Brückner MK, Rozemuller AJ, Veerhuis R, Eikelenboom P, Arendt T. Cyclin D1 and cyclin E are co-localized with cyclo-oxygenase 2 (COX-2) in pyramidal neurons in Alzheimer disease temporal cortex. J Neuropathol Exp Neurol 2002; 61:678-88. (Pubitemid 34851771)
33. Woods J, Snape M, Smith MA. The cell cycle hypothesis of Alzheimer's disease: suggestions for drug development. Biochim Biophys Acta 2007; 1772:503-8.
34. McShea A, Lee HG, Petersen RB, Casadesus G, Vincent I, Linford NJ, et al. Neuronal cell cycle re-entry mediates Alzheimer disease-type changes. Biochim Biophys Acta 2007; 1772:467-72.
35. Park KH, Hallows JL, Chakrabarty P, Davies P, Vincent I. Conditional neuronal simian virus 40 T antigen expression induces Alzheimer-like tau and amyloid pathology in mice. J Neurosci 2007; 27:2969-78.
36. Lee HG, Casadesus G, Nunomura A, Zhu X, Castellani RJ, Richardson SL, et al. The neuronal expression of Myc causes a neurodegenerative phenotype in a novel transgenic mouse. Am J Pathol 2009; 174:891-7.
37. Yang Y, Varvel NH, Lamb BT, Herrup K. Ectopic cell cycle events link human Alzheimer's disease and amyloid precursor protein transgenic mouse models. J Neurosci 2006; 26:775-84.
38. Ahn KW, Joo Y, Choi Y, Kim M, Lee SH, Cha SH, et al. Swedish amyloid precursor protein mutation increases cell cycle-related proteins in vitro and in vivo. J Neurosci Res 2008; 86:2476-87.
39. Malik B, Currais A, Andres A, Towlson C, Pitsi D, Nunes A, et al. Loss of neuronal cell cycle control as a mechanism of neurodegeneration in the presenilin-1 Alzheimer's disease brain. Cell Cycle 2008; 7:637-46.
40. Khurana V, Lu Y, Steinhilb ML, Oldham S, Shulman JM, Feany MB. TOR-mediated cell cycle activation causes neurodegeneration in a Drosophila tauopathy model. Curr Biol 2006; 16:230-41.
41. Feddersen RM, Ehlenfeldt R, Yunis WS, Clark HB, Orr HT. Disrupted cerebellar cortical development and progressive degeneration of Purkinje cells in SV40 T antigen transgenic mice. Neuron 1992; 9:955-66.
42. Al-Ubaidi MR, Hollyfield JG, Overbeek PA, Baehr W. Photoreceptor degeneration induced by the expression of simian virus 40 large tumor antigen in the retina of transgenic mice. Proc Natl Acad Sci USA 1992; 89:1194-8.
43. Bowser R, Smith MA. Cell cycle proteins in Alzheimer's disease: plenty of wheels but no cycle. J Alzheimers Dis 2002; 4:249-54.
44. Spremo-Potparevic B, Zivkovic L, Djelic N, Bajic V. Analysis of premature centromere division (PCD) of the X chromosome in Alzheimer patients through the cell cycle. Exp Gerontol 2004; 39:849-54.
45. Iourov IY, Vorsanova SG, Liehr T, Yurov YB. Aneuploidy in the normal, Alzheimer's disease and ataxia-telangiectasia brain: differential expression and pathological meaning. Neurobiol Dis 2009; 34:212-20.
46. Mosch B, Morawski M, Mittag A, Lenz D, Tarnok A, Arendt T. Aneuploidy and DNA replication in the normal human brain and Alzheimer's disease. J Neurosci 2007; 27:6859-67.
47. Westra JW, Barral S, Chun J. A Reevaluation of Tetraploidy in the Alzheimer's Disease Brain. Neurodegener Dis 2009; 6:221-9.
48. Rehen SK, Yung YC, McCreight MP, Kaushal D, Yang AH, Almeida BS, et al. Constitutional aneuploidy in the normal human brain. J Neurosci 2005; 25:2176-80.
49. Kingsbury MA, Yung YC, Peterson SE, Westra JW, Chun J. Aneuploidy in the normal and diseased brain. Cell Mol Life Sci 2006; 63:2626-41.
50. Spremo-Potparevic B, Zivkovic L, Djelic N, Plecas-Solarovic B, Smith MA, Bajic V. Premature centromere division of the X chromosome in neurons in Alzheimer's disease. Neurochem 2008; 106:2218-23.
51. Edgar BA, Orr-Weaver TL. Endoreplication cell cycles: more for less. Cell 2001; 105:297-306.
52. Ullah Z, Lee CY, Lilly MA, DePamphilis ML. Developmentally programmed endoreduplication in animals. Cell Cycle 2009; 8:1501-9.
53. Arendt T, Rödel L, Gärtner U, Holzer M. Expression of the cyclin-dependent kinase inhibitor p16 in Alzheimer's disease. Neuroreport 1996; 7:3047-9.
54. Arendt T, Holzer M, Gärtner U. Neuronal expression of cycline dependent kinase inhibitors of the INK4 family in Alzheimer's disease. J Neural Transm 1998; 105:949-60.
55. INK4a. Brain Res 2000; 852:45-55.
56. Ogawa O, Lee HG, Zhu X, Raina A, Harris PL, Castellani RJ, et al. Increased p27, an essential component of cell cycle control, in Alzheimer's disease. Aging Cell 2003; 2:105-10.
57. Morillo SM, Escoll P, de la Hera A, Frade JM. Somatic tetraploidy in specific chick retinal ganglion cells induced by nerve growth factor. Proc Natl Acad Sci USA 2010; 107:109-14.
58. Frade JM. Unscheduled re-entry into the cell cycle induced by NGF precedes cell death in nascent retinal neurones. J Cell Sci 2000; 113:1139-48.
59. Becker EB, Bonni A. Cell cycle regulation of neuronal apoptosis in development and disease. Prog Neurobiol 2004; 72:1-25.
60. Cotman CW, Anderson AJ. A potential role for apoptosis in neurodegeneration and Alzheimer's disease. Mol Neurobiol 1995; 10:19-45.
61. Zhu X, Raina AK, Perry G, Smith MA. Apoptosis in Alzheimer disease: a mathematical improbability. Curr Alzheimer Res 2006; 3:393-6.
62. Raina AK, Hochman A, Zhu X, Rottkamp CA, Nunomura A, Siedlak SL, et al. Abortive apoptosis in Alzheimer's disease. Acta Neuropathol 2001; 101:305-10.
63. Szaro BG, Tompkins R. Effect of tetraploidy on dendritic branching in neurons and glial cells of the frog, Xenopus laevis. J Comp Neurol 1987; 258:304-16.
64. Arendt T, Zvegintseva HG, Leontovich TA. Dendritic changes in the basal nucleus of Meynert and in the diagonal band nucleus in Alzheimer's disease. A quantitative Golgi investigation. Neuroscience 1986; 19:1265-78.
65. Iraizoz I, de Lacalle S, Gonzalo LM. Cell loss and nuclear hypertrophy in topographical subdivisions of the nucleus basalis of Meynert in Alzheimer's disease. Neuroscience 1991; 41:33-40.
66. Oh ES, Savonenko AV, King JF, Fangmark Tucker SM, Rudow GL, et al. Amyloid precursor protein increases cortical neuron size in transgenic mice. Neurobiol Aging 2009; 30:1238-44.
67. Salehi A, Delcroix JD, Swaab DF. Alzheimer's disease and NGF signaling. J Neural Transm 2004; 111:323-45.
68. Meier-Ruge W, Ulrich J, Stähelin HB. Morphometric investigation of nerve cells, neuropil and senile plaques in senile dementia of the Alzheimer type. Arch Gerontol Geriatr 1985; 4:219-29.
69. Bundgaard MJ, Regeur L, Gundersen HJ, Pakkenberg B. Size of neocortical neurons in control subjects and in Alzheimer's disease. J Anat 2001; 198:481-9.
70. Riudavets MA, Iacono D, Resnick SM, O'Brien R, Zonderman AB, Martin LJ, et al. Resistance to Alzheimer's pathology is associated with nuclear hypertrophy in neurons. Neurobiol Aging 2007; 28:1484-92.
71. Iacono D, O'Brien R, Resnick SM, Zonderman AB, Pletnikova O, Rudow G, et al. Neuronal hypertrophy in asymptomatic Alzheimer disease. J Neuropathol Exp Neurol 2008; 67:578-89.
72. Iacono D, Pletnikova O, Rudow G, Patel E, Tudor D, Markesbery W, Snowdon D, et al. Asymptomatic AD is associated with hypertrophy of CA1-hippocampus neurons in the NUN study. FASEB J 2008; 22:702-7.
73. Iacono D, Markesbery WR, Gross M, Pletnikova O, Rudow G, Zandi P, et al. The Nun study: clinically silent AD, neuronal hypertrophy, and linguistic skills in early life. Neurology 2009; 73:665-73.
74. Jansen P, Giehl K, Nyengaard JR, Teng K, Lioubinski O, Sjoegaard SS, et al. Roles for the pro-neurotrophin receptor sortilin in neuronal development, aging and brain injury. Nat Neurosci 2007; 10:1449-57.
75. Nakamura K, Namekata K, Harada C, Harada T. Intracellular sortilin expression pattern regulates proNGF-induced naturally occurring cell death during development. Cell Death Differ 2007; 14:1552-4.
76. Chao MV, Bothwell MA, Ross AH, Koprowski H, Lanahan AA, Buck CR, et al. Gene transfer and molecular cloning of the human NGF receptor. Science 1986; 232:518-21.
77. Klein R, Jing SQ, Nanduri V, O'Rourke E, Barbacid M. The trk proto-oncogene encodes a receptor for nerve growth factor. Cell 1991; 65:189-97.
78. NTR is positively promiscuous: novel partners and new insights. Neuron 2004; 42:529-33.
79. López-Sánchez N, Frade JM. Control of the cell cycle by neurotrophins: lessons from the p75 neurotrophin receptor. Histol Histopathol 2002; 17:1227-37.
80. Dechant G, Barde YA. The neurotrophin receptor p75(NTR): novel functions and implications for diseases of the nervous system. Nat Neurosci 2002; 5:1131-6.
81. Diarra A, Geetha T, Potter P, Babu JR. Signaling of the neurotrophin receptor p75 in relation to Alzheimer's disease. Biochem Biophys Res Commun 2009; 390:352-6.
82. Coulson EJ, May LM, Sykes AM, Hamlin AS. The role of the p75 neurotrophin receptor in cholinergic dysfunction in Alzheimer's disease. Neuroscientist 2009; 15:317-23.
83. Springer JE, Koh S, Tayrien MW, Loy R. Basal forebrain magnocellular neurons stain for nerve growth factor receptor: correlation with cholinergic cell bodies and effects of axotomy. J Neurosci Res 1987; 17:111-8.
84. Hu XY, Zhang HY, Qin S, Xu H, Swaab DF, Zhou JN. Increased p75(NTR) expression in hippocampal neurons containing hyperphosphorylated tau in Alzheimer patients. Exp Neurol 2002; 178:104-11.
85. Yaar M, Zhai S, Pilch PF, Doyle SM, Eisenhauer PB, Fine RE, et al. Binding of beta-amyloid to the p75 neurotrophin receptor induces apoptosis. A possible mechanism for Alzheimer's disease. J Clin Invest 1997; 100:2333-40.
86. Sotthibundhu A, Sykes AM, Fox B, Underwood CK, Thangnipon W, Coulson EJ. Beta-amyloid(1-42) induces neuronal death through the p75 neurotrophin receptor. J Neurosci 2008; 28:3941-6.
87. Knowles JK, Rajadas J, Nguyen TV, Yang T, LeMieux MC, Vander Griend L, et al. The p75 neurotrophin receptor promotes amyloid-beta(1-42)-induced neuritic dystrophy in vitro and in vivo. J Neurosci 2009; 29:10627-37.
88. Susen K, Blöchl A. Low concentrations of aggregated beta-amyloid induce neurite formation via the neurotrophin receptor p75. J Mol Med 2005; 83:720-35.
89. Arendt T, Holzer M, Grossmann A, Zedlick D, Brückner MK. Increased expression and subcellular translocation of the mitogen activated protein kinase kinase and mitogen-activated protein kinase in Alzheimer's disease. Neuroscience 1995; 68:5-18.
90. ras in Alzheimer pathology. Neuroreport 1995; 6:1441-4.
91. Fombonne J, Rabizadeh S, Banwait S, Mehlen P, Bredesen DE. Selective vulnerability in Alzheimer's disease: amyloid precursor protein and p75(NTR) interaction. Ann Neurol 2009; 65:294-303.
92. Cozza A, Melissari E, Iacopetti P, Mariotti V, Tedde A, Nacmias B, et al. SNPs in neurotrophin system genes and Alzheimer's disease in an Italian population. J Alzheimers Dis 2008; 15:61-70.
93. Lee R, Kermani P, Teng KK, Hempstead BL. Regulation of cell survival by secreted proneurotrophins. Science 2001; 294:1945-8.
94. Fahnestock M, Michalski B, Xu B, Coughlin MD. The precursor pro-nerve growth factor is the predominant form of nerve growth factor in brain and is increased in Alzheimer's disease. Mol Cell Neurosci 2001; 18:210-20.
95. Al-Shawi R, Hafner A, Chun S, Raza S, Crutcher K, Thrasivoulou C, et al. ProNGF, sortilin and age-related neurodegeneration. Ann NY Acad Sci 2007; 1119:208-15.
96. Al-Shawi R, Hafner A, Olsen J, Chun S, Raza S, Thrasivoulou C, et al. Neurotoxic and neurotrophic roles of proNGF and the receptor sortilin in the adult and ageing nervous system. Eur J Neurosci 2008; 27:2103-14.
97. Nykjaer A, Lee R, Teng KK, Jansen P, Madsen P, Nielsen MS, et al. Sortilin is essential for proNGF-induced neuronal cell death. Nature 2004; 427:843-8.
98. Fahnestock M, Yu G, Coughlin MD. ProNGF: a neurotrophic or an apoptotic molecule? Prog Brain Res 2004; 146:101-10.
99. Hock C, Heese K, Hulette C, Rosenberg C, Otten U. Region-specific neurotrophin imbalances in Alzheimer disease: decreased levels of brain-derived neurotrophic factor and increased levels of nerve growth factor in hippocampus and cortical areas. Arch Neurol 2000; 57:846-51.
100. Crutcher KA, Scott SA, Liang S, Everson WV, Weingartner J. Detection of NGF-like activity in human brain tissue: increased levels in Alzheimer's disease. J Neurosci 1993; 13:2540-50.
101. NTR. Am J Pathol 2005; 166:533-43.
102. Peng S, Wuu J, Mufson EJ, Fahnestock M. Increased proNGF levels in subjects with mild cognitive impairment and mild Alzheimer disease. J Neuropathol Exp Neurol 2004; 63:641-9.
103. Narisawa-Saito M, Wakabayashi K, Tsuji S, Takahashi H, Nawa H. Regional specificity of alterations in NGF, BDNF and NT-3 levels in Alzheimer's disease. Neuroreport 1996; 7:2925-8.
104. Scott SA, Mufson EJ, Weingartner JA, Skau KA, Crutcher KA. Nerve growth factor in Alzheimer's disease: increased levels throughout the brain coupled with declines in nucleus basalis. J Neurosci 1995; 15:6213-21.
105. Smith MA, Rottkamp CA, Nunomura A, Raina AK, Perry G. Oxidative stress in Alzheimer's disease. Biochim Biophys Acta 2000; 1502:139-44.
106. Nunomura A, Perry G, Aliev G, Hirai K, Takeda A, Balraj EK, et al. Oxidative damage is the earliest event in Alzheimer disease. J Neuropathol Exp Neurol 2001; 60:759-67.
107. Keller JN, Schmitt FA, Scheff SW, Ding Q, Chen Q, Butterfield DA, et al. Evidence of increased oxidative damage in subjects with mild cognitive impairment. Neurology 2005; 64:1152-6.
108. Smith MA, Taneda S, Richey PL, Miyata S, Yan SD, Stern D, et al. Advanced Maillard reaction end products are associated with Alzheimer disease pathology. Proc Natl Acad Sci USA 1994; 91:5710-4.
109. Smith MA, Rudnicka-Nawrot M, Richey PL, Praprotnik D, Mulvihill P, Miller CA, et al. Carbonyl-related posttranslational modification of neurofilament protein in the neurofibrillary pathology of Alzheimer's disease. J Neurochem 1995; 64:2660-6.
110. Smith MA, Richey Harris PL, Sayre LM, Beckman JS, Perry G. Widespread peroxynitrite-mediated damage in Alzheimer's disease. J Neurosci 1997; 17:2653-7.
111. Sayre LM, Zelasko DA, Harris PL, Perry G, Salomon RG, Smith MA. 4-Hydroxynonenal-derived advanced lipid peroxidation end products are increased in Alzheimer's disease. J Neurochem 1997; 68:2092-7.
112. Zhu X, Raina AK, Perry G, Smith MA. Alzheimer's disease: the two-hit hypothesis. Lancet Neurol 2004; 3:219-26.
113. Kichev A, Ilieva EV, Piñol-Ripoll G, Podlesniy P, Ferrer I, Portero-Otín M, et al. Cell death and learning impairment in mice caused by in vitro modified pro-NGF can be related to its increased oxidative modifications in Alzheimer disease. Am J Pathol 2009; 175:2574-85.
114. Dobrowsky RT, Carter BD. p75 neurotrophin receptor signaling: mechanisms for neurotrophic modulation of cell stress? J Neurosci Res 2000; 61:237-43.
115. Olivieri G, Otten U, Meier F, Baysang G, Dimitriades-Schmutz B, Müller-Spahn F, et al. Oxidative stress modulates tyrosine kinase receptor A and p75 receptor (low-affinity nerve growth factor receptor) expression in SHSY5Y neuroblastoma cells. Neurol Clin Neurophysiol 2002; 2002:2-10.
116. Ali TK, Matragoon S, Pillai BA, Liou GI, El-Remessy AB. Peroxynitrite mediates retinal neurodegeneration by inhibiting nerve growth factor survival signaling in experimental and human diabetes. Diabetes 2008; 57:889-98.
117. Vargas MR, Pehar M, Cassina P, Estévez AG, Beckman JS, Barbeito L. Stimulation of nerve growth factor expression in astrocytes by peroxynitrite. In Vivo 2004; 18:269-74.
118. Leung E, Guo L, Bu J, Maloof M, Khoury JE, Geula C. Microglia activation mediates fibrillar amyloid-beta toxicity in the aged primate cortex. Neurobiol Aging 2009; doi: 10.1016/j.neurobiolaging.2009.02.025.
119. Delgado M, Varela N, Gonzalez-Rey E. Vasoactive intestinal peptide protects against beta-amyloid-induced neurodegeneration by inhibiting microglia activation at multiple levels. Glia 2008; 56:1091-103.
120. González-Scarano F, Baltuch G. Microglia as mediators of inflammatory and degenerative diseases. Annu Rev Neurosci 1999; 22:219-40.
121. Colton CA, Gilbert DL. Production of superoxide anions by a CNS macrophage, the microglia. FEBS Lett 1987; 223:284-8.
122. Mrak RE, Sheng JG, Griffin WS. Glial cytokines in Alzheimer's disease: review and pathogenic implications. Hum Pathol 1995; 26:816-23.
123. Elkabes S, DiCicco-Bloom EM, Black IB. Brain microglia/macrophages express neurotrophins that selectively regulate microglial proliferation and function. J Neurosci 1996; 16:2508-21.
124. Heese K, Fiebich BL, Bauer J, Otten U. Nerve growth factor (NGF) expression in rat microglia is induced by adenosine A2a-receptors. Neurosci Lett 1997; 231:83-6.
125. Frade JM, Barde YA. Microglia-derived nerve growth factor causes cell death in the developing retina. Neuron 1998; 20:35-41.
126. Srinivasan B, Roque CH, Hempstead BL, Al-Ubaidi MR, Roque RS. Microglia-derived pronerve growth factor promotes photoreceptor cell death via p75 neurotrophin receptor. J Biol Chem 2004; 279:41839-45.
127. Heese K, Hock C, Otten U. Inflammatory signals induce neurotrophin expression in human microglial cells. J Neurochem 1998; 70:699-707.
128. Wu Q, Combs C, Cannady SB, Geldmacher DS, Herrup K. Beta-amyloid activated microglia induce cell cycling and cell death in cultured cortical neurons. Neurobiol Aging 2000; 21:797-806.
129. NTR-dependent tau hyperphosphorylation in cultured hippocampal neurons. J Neurosci Res 2006; 84:1098-106.
130. Anatskaya OV, Vinogradov AE. Genome multiplication as adaptation to tissue survival: evidence from gene expression in mammalian heart and liver. Genomics 2007; 89:70-80.
131. Kawaguchi J, Kano K, Naito K. Expression Profiling of Tetraploid Mouse Embryos in the Developmental Stages Using a cDNA Microarray Analysis. J Reprod Dev 2009; doi: 10.1262/jrd.09-127A.
132. Sizova D, Charbaut E, Delalande F, Poirier F, High AA, Parker F, et al. Proteomic analysis of brain tissue from an Alzheimer's disease mouse model by two-dimensional difference gel electrophoresis. Neurobiol Aging 2007; 28:357-70.
133. Wilson KE, Marouga R, Prime JE, Pashby DP, Orange PR, Crosier S, et al. Comparative proteomic analysis using samples obtained with laser microdissection and saturation dye labelling. Proteomics 2005; 5:3851-8.
134. Vercauteren FG, Clerens S, Roy L, Hamel N, Arckens L, Vandesande F, et al. Early dysregulation of hippocampal proteins in transgenic rats with Alzheimer's disease-linked mutations in amyloid precursor protein and presenilin 1. Brain Res Mol Brain Res 2004; 132:241-59.
135. Husseman JW, Hallows JL, Bregman DB, Leverenz JB, Nochlin D, Jin LW, et al. Hyperphosphorylation of RNA polymerase II and reduced neuronal RNA levels precede neurofibrillary tangles in Alzheimer disease. J Neuropathol Exp Neurol 2001; 60:1219-32.
136. Jagust WJ, Seab JP, Huesman RH, Valk PE, Mathis CA, Reed BR, et al. Diminished glucose transport in Alzheimer's disease: dynamic PET studies. J Cereb Blood Flow Metab 1991; 11:323-30.
137. Pettegrew JW, Klunk WE, Panchalingam K, McClure RJ, Stanley JA. Magnetic resonance spectroscopic changes in Alzheimer's disease. Ann NY Acad Sci 1997; 826:282-306.
138. Stefani M, Liguri G. Cholesterol in Alzheimer's disease: unresolved questions. Curr Alzheimer Res 2009; 6:15-29.
139. Ignatius MJ, Shooter EM, Pitas RE, Mahley RW. Lipoprotein uptake by neuronal growth cones in vitro. Science 1987; 236:959-62.
140. Maysinger D, Holmes M, Han X, Epand RM, Pertens E, Foerster A, et al. Ceramide is responsible for the failure of compensatory nerve sprouting in apolipoprotein E knock-out mice. J Neurosci 2008; 28:7891-9.
141. Dumanis SB, Tesoriero JA, Babus LW, Nguyen MT, Trotter JH, Ladu MJ, et al. ApoE4 decreases spine density and dendritic complexity in cortical neurons in vivo. J Neurosci 2009; 29:15317-22.
142. Geddes JW, Monaghan DT, Cotman CW, Lott IT, Kim RC, Chui HC. Plasticity of hippocampal circuitry in Alzheimer's disease. Science 1985; 230:1179-81.
143. Cotman CW, Geddes JW, Kahle JS. Axon sprouting in the rodent and Alzheimer's disease brain: a reactivation of developmental mechanisms? Prog Brain Res 1990; 83:427-34.
144. Masliah E, Mallory M, Hansen L, Alford M, Albright T, DeTeresa R, et al. Patterns of aberrant sprouting in Alzheimer's disease. Neuron 1991; 6:729-39.
145. Phinney AL, Deller T, Stalder M, Calhoun ME, Frotscher M, Sommer B, et al. Cerebral amyloid induces aberrant axonal sprouting and ectopic terminal formation in amyloid precursor protein transgenic mice. J Neurosci 1999; 19:8552-9.
146. Arendt T. Disturbance of neuronal plasticity is a critical pathogenetic event in Alzheimer's disease. Int J Dev Neurosci 2001; 19:231-45.
147. Chin J, Palop JJ, Yu GQ, Kojima N, Masliah E, Mucke L. Fyn kinase modulates synaptotoxicity, but not aberrant sprouting, in human amyloid precursor protein transgenic mice. J Neurosci 2004; 24:4692-7.
148. Palop JJ, Chin J, Roberson ED, Wang J, Thwin MT, Bien-Ly N, et al. Aberrant excitatory neuronal activity and compensatory remodeling of inhibitory hippocampal circuits in mouse models of Alzheimer's disease. Neuron 2007; 55:697-711.
149. Wang SS, Shultz JR, Burish MJ, Harrison KH, Hof PR, Towns LC, et al. Functional trade-offs in white matter axonal scaling. J Neurosci 2008; 28:4047-56.
150. Small SA, Duff K. Linking Abeta and tau in late-onset Alzheimer's disease: a dual pathway hypothesis. Neuron 2008; 60:534-42.
151. Braak H, Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 1991; 82:239-59.
152. NTR Neurotrophin Receptor in SHSY5Y Human Neuroblastoma Cells and AD Transgenic Mice. J Alzheimers Dis 2010; 19:915-25.
153. Frasca G, Chiechio S, Vancheri C, Nicoletti F, Copani A, Angela Sortino M. Beta-amyloid-activated cell cycle in SH-SY5Y neuroblastoma cells: correlation with the MAP kinase pathway. J Mol Neurosci 2004; 22:231-6.
154. Shieh PB, Ghosh A. Molecular mechanisms underlying activity-dependent regulation of BDNF expression. J Neurobiol 1999; 41:127-34.
155. Murer MG, Yan Q, Raisman-Vozari R. Brain-derived neurotrophic factor in the control human brain, and in Alzheimer's disease and Parkinson's disease. Prog Neurobiol 2001; 63:71-124.
156. Siegel GJ, Chauhan NB. Neurotrophic factors in Alzheimer's and Parkinson's disease brain. Brain Res Brain Res Rev 2000; 33:199-227.
157. Ferrer I, Marín C, Rey MJ, Ribalta T, Goutan E, Blanco R, et al. BDNF and full-length and truncated TrkB expression in Alzheimer disease. Implications in therapeutic strategies. J. Neuropathol Exp Neurol 1999; 58:729-39.
158. Allen SJ, Wilcock GK, Dawbarn D. Profound and selective loss of catalytic TrkB immunoreactivity in Alzheimer's disease. Biochem Biophys Res Commun 1999; 264:648-51.
159. Ogawa O, Zhu X, Lee HG, Raina A, Obrenovich ME, Bowser R, et al. Ectopic localization of phosphorylated histone H3 in Alzheimer's disease: a mitotic catastrophe? Acta Neuropathol 2003; 105:524-8.
160. Zhu X, Siedlak SL, Wang Y, Perry G, Castellani RJ, Cohen ML, et al. Neuronal binucleation in Alzheimer disease hippocampus. Neuropathol Appl Neurobiol 2008; 34:457-65.
161. Ventriglia M, Bocchio Chiavetto L, Benussi L, Binetti G, Zanetti O, Riva MA, et al. Association between the BDNF 196 A/G polymorphism and sporadic Alzheimer's disease. Mol Psychiatry 2002; 7:136-7.
162. Kunugi H, Ueki A, Otsuka M, Isse K, Hirasawa H, Kato N, et al. A novel polymorphism of the brain-derived neurotrophic factor (BDNF) gene associated with late-onset Alzheimer's disease. Mol Psychiatry 2001; 6:83-6.
163. Nishimura AL, Oliveira JR, Mitne-Neto M, Guindalini C, Nitrini R, Bahia VS, et al. Lack of association between the brain-derived neurotrophin factor (C-270T) polymorphism and late-onset Alzheimer's disease (LOAD) in Brazilian patients. J Mol Neurosci 2004; 22:257-60.
164. Tsai SJ, Hong CJ, Liu HC, Liu TY, Hsu LE, Lin CH. Association analysis of brain-derived neurotrophic factor Val66Met polymorphisms with Alzheimer's disease and age of onset. Neuropsychobiology 2004; 49:10-2.
165. Chen Z, Simmons MS, Perry RT, Wiener HW, Harrell LE, Go RC. Genetic association of neurotrophic tyrosine kinase receptor type 2 (NTRK2) with Alzheimer's disease. Am J Med Genet B Neuropsychiatr Genet 2008; 147:363-9.